Evolent Health, Inc. (EVH) on GreekSoup https://greeksoup.ai/stocks/us/evh/ Every dated entry in the public record on Evolent Health, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Evolent Health, Inc.: short interest 11,901,743 shares at the 15 October 2026 settlement, 5.62 days to coverhttps://greeksoup.ai/stocks/us/evh/short-interest/us:EVH:short-interest:2026-10-15:f33062a241Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Evolent Health, Inc.: short interest 12,906,700 shares at the 30 September 2026 settlement, 5.47 days to coverhttps://greeksoup.ai/stocks/us/evh/short-interest/us:EVH:short-interest:2026-09-30:0c004b601dWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Evolent Health, Inc.: short interest 14,068,069 shares at the 15 September 2026 settlement, 5.81 days to coverhttps://greeksoup.ai/stocks/us/evh/short-interest/us:EVH:short-interest:2026-09-15:7269ef5795Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Evolent Health, Inc.: Schedule 13G/A filed by Morgan Stanley, 2.7% of the classhttps://greeksoup.ai/stocks/us/evh/holders/us:EVH:schedule-13:2026-09-08:da533c9d0bTue, 08 Sep 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Evolent Health, Inc.: short interest 15,469,700 shares at the 31 August 2026 settlement, 5.83 days to coverhttps://greeksoup.ai/stocks/us/evh/short-interest/us:EVH:short-interest:2026-08-31:39e99d8897Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Evolent Health, Inc.: Mccarthy Daniel Joseph (PRESIDENT) sold 65,892 shares (under a trading plan set in advance) at $5.00 on 26 August 2026, $329,460https://greeksoup.ai/stocks/us/evh/insiders/us:EVH:insider:2026-08-28:19ca7c47b6Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Evolent Health, Inc.: Form 144, Daniel McCarthy plans to sell 65,892 shares worth $327,476 around 26 August 2026https://greeksoup.ai/stocks/us/evh/planned-sales/us:EVH:planned-sale:2026-08-26:d2171c7610Wed, 26 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Evolent Health, Inc.: short interest 15,773,309 shares at the 14 August 2026 settlement, 3.95 days to coverhttps://greeksoup.ai/stocks/us/evh/short-interest/us:EVH:short-interest:2026-08-14:a33f267ab6Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Evolent Health, Inc. Q2 FY2026 results: revenue $653 million, net income -$28 millionhttps://greeksoup.ai/stocks/us/evh/results/fy2026-q2/us:EVH:result:2026-08-06:9894b67892Thu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Evolent Health, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/evh/filings/us:EVH:filing:2026-08-06:a83f50b67aThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Evolent Health, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/evh/filings/us:EVH:filing:2026-08-06:8bf4834658Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>